Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary.

Malik, Shakun M; Liu, Ke; Qiang, Xu; Sridhara, Rajeshwari; Tang, Shenghui; McGuinn, W David; Verbois, S Leigh; Marathe, Anshu; Williams, Gene M; Bullock, Julie; Tornoe, Christoffer; Lin, Sue Ching; Ocheltree, Terrance; Vialpando, Milinda; Kacuba, Alice; Justice, Robert; Pazdur, Richard

Malik, Shakun M; Liu, Ke; Qiang, Xu; Sridhara, Rajeshwari; Tang, Shenghui; McGuinn, W David; Verbois, S Leigh; Marathe, Anshu; Williams, Gene M; Bullock, Julie; Tornoe, Christoffer; Lin, Sue Ching; Ocheltree, Terrance; Vialpando, Milinda; Kacuba, Alice; Justice, Robert; Pazdur, Richard.

Affiliation

Malik SM; Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. shakun.malik@fda.hhs

Clin Cancer Res ; 16(20): 4921-7, 2010 Oct 15.

Article in En | MEDLINE | ID: mdl-20739433

Subject(s)

Aminopterin/analogs & derivatives; Lymphoma, T-Cell/drug therapy; Aged; Aminopterin/adverse effects; Aminopterin/chemistry; Aminopterin/therapeutic use; Drug Approval; Female; Folic Acid Antagonists/adverse effects; Folic Acid Antagonists/chemistry; Folic Acid Antagonists/therapeutic use; Humans; Male; Middle Aged; United States; United States Food and Drug Administration

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell / Aminopterin Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2010 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google